In the fields of synthetic biology and cell therapy, precise control of gene expression in response to specific cellular states is crucial for both functional studies and therapeutic applications.
SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback